Phase 1 dose-finding study investigating CA-4948, an IRAK4 kinase inhibitor, in patients with R/R NHL: Report of initial efficacy and updated safety information Meeting Abstract
| Authors: | Younes, A.; Nowakowski, G.; Rosenthal, A. C.; Leslie, L. A.; Tun, H. W.; Lunning, M. A.; Isufi, I.; Martell, R.; Patel, K. |
| Abstract Title: | Phase 1 dose-finding study investigating CA-4948, an IRAK4 kinase inhibitor, in patients with R/R NHL: Report of initial efficacy and updated safety information |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164606046 |
| DOI: | 10.1182/blood-2019-131851 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5327 -- Source: Wos |
